loading

Finanzdaten der Vertex Pharmaceuticals Inc-Aktie (VRTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
3.69%
3,190.00
3,076.40 2,964.70 2,770.20 2,912.00
Cost Of Revenue
12.34%
466.00
414.80 407.50 363.00 423.40
Gross Profit
2.34%
2,724.00
2,661.60 2,557.20 2,407.20 2,488.60
Operating Expenses
2.89%
1,518.10
1,475.40 1,406.10 1,777.10 1,462.60
Benefits Costs and Expenses
4.58%
1,859.00
1,777.60 1,681.70 2,039.80 1,775.50
Costs And Expenses
4.97%
1,984.10
1,890.20 1,813.60 2,140.10 1,886.00
Operating Income/Loss
1.66%
1,205.90
1,186.20 1,151.10 630.10 1,026.00
Income/Loss From Continuing Operations Before Tax
2.48%
1,331.00
1,298.80 1,283.00 730.40 1,136.50
Income Tax Expense/Benefit
35.20%
139.90
215.90 250.10 84.10 223.50
Income/Loss From Continuing Operations After Tax
9.99%
1,191.10
1,082.90 1,032.90 646.30 913.00
Net Income/Loss
9.99%
1,191.10
1,082.90 1,032.90 646.30 913.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
100.27%
-0.70
255.60 256.70 256.90 -0.20
Diluted Average Shares
100.23%
-0.60
257.60 258.90 259.50 -0.20
Basic Earnings Per Share
10.61%
4.69
4.24 4.02 2.52 3.53
Diluted Earnings Per Share
10.48%
4.64
4.20 3.99 2.49 3.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$755.00
price up icon 0.87%
$711.09
price up icon 0.44%
$312.32
price down icon 1.50%
biotechnology ONC
$288.30
price up icon 0.99%
$141.15
price up icon 1.23%
Kapitalisierung:     |  Volumen (24h):